tiprankstipranks
Trending News
More News >
Kezar Life Sciences Inc (KZR)
NASDAQ:KZR
US Market

Kezar Life Sciences (KZR) Income Statement

Compare
476 Followers

Kezar Life Sciences Income Statement

Last quarter (Q3 2025), Kezar Life Sciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Kezar Life Sciences's net income was $-11.23M. See Kezar Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 7.00M$ 0.00$ 0.00$ 0.00
Gross Profit
$ -1.04M$ 7.00M$ 0.00$ -1.51M$ -1.54M
Operating Expenses
$ 90.61M$ 118.42M$ 71.16M$ 53.15M$ 41.46M
Depreciation and Amortization
$ 1.04M$ 1.07M$ 1.02M$ 1.51M$ 1.54M
EBITDA
$ -81.10M$ -99.25M$ -66.03M$ -52.96M$ -40.26M
Operating Income
$ -90.61M$ -111.42M$ -71.16M$ -54.66M$ -43.01M
Other Income/Expenses
$ 6.87M$ 9.55M$ 2.92M$ 29.00K$ 1.21M
Pretax Income
$ -83.74M$ -101.87M$ -68.24M$ -54.63M$ -41.80M
Net Income
$ -83.74M$ -101.87M$ -68.24M$ -54.63M$ -41.74M
Per Share Metrics
Basic EPS
$ -1.15$ -1.40$ -1.01$ -1.04$ -0.95
Diluted EPS
$ -1.15$ -1.40$ -1.01$ -1.04$ -0.95
Weighted Average Shares Outstanding
72.90M 72.55M 67.37M 52.76M 44.00M
Weighted Average Shares Outstanding (Diluted)
72.90M 72.55M 67.37M 52.76M 44.00M
Currency in USD

Kezar Life Sciences Earnings and Revenue History